Comparison of membranes used in the treatment of end-stage renal failure.
Hoenich
N A
NA
Department of Medicine, Medical School, University of Newcastle upon Tyne, United Kingdom.
Stenton
S C
SC
Woffindin
C
C
Levett
D
D
Fawcett
S
S
Quereshi
M
M
Tapson
J S
JS
Ward
M K
MK
D001672:Biocompatible Materials; D003167:Complement Activation; D006801:Humans; D007688:Kidneys, Artificial / Q000009:adverse effects; D007970:Leukopenia / Q000209:etiology; D008567:Membranes, Artificial; D014165:Transfer Factor / Q000097:blood
D001672:Biocompatible Materials; D008567:Membranes, Artificial; D014165:Transfer Factor